Johnson & Johnson: Pain, Postoperative trials

The registry lists 16 Pain, Postoperative studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 3Phase 3 7Phase 4 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study Comparing the Effectiveness and Safety of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen With Immediate Release (IR) Tramadol HCl/Acetaminophen in Participants With Moderate to Severe Postoperative PainCompletedNCT01814878Phase 3Results posted
• A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery PainTerminatedNCT01804673Phase 4Results posted
• A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain SyndromeCompletedNCT01008553Phase 3Results posted
• Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder SurgeryCompletedNCT00814580Phase 3Results posted
• Safety and Efficacy Study of Fentanyl Iontophoretic Transdermal System (ITS) for Management of Moderate to Severe Acute Pain in Participants Who Have Undergone Elective Spine or Orthopedic SurgeryTerminatedNCT00779038Phase 4Results posted
• An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic SurgeryTerminatedNCT00766506Phase 4Results posted
• A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction PainCompletedNCT00737048Phase 3Results posted
• Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and AdolescentsCompletedNCT01134536Phase 2
• A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or IntravenouslyCompletedNCT00996177Phase 4
• Bioequivalence Between Integrated E-TRANS (Fentanyl) System and Separated (Two-Part) E-TRANS (Fentanyl) SystemCompletedNCT00990418Phase 1
• A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy SurgeryCompletedNCT00806247Phase 2
• An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric PatientsWithdrawnNCT00666393Phase 3
• A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative PainCompletedNCT00411307Phase 2
• A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Scheduled Abdominal or Pelvic Surgery: The Fentanyl Transdermal System Versus the Morphine Intravenous PumpCompletedNCT00266539Phase 3
• A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Total Hip Replacement: The E-TRANS Fentanyl Transdermal System Versus the Morphine Intravenous PumpCompletedNCT00264485Phase 3
• A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral SurgeryCompletedNCT00236483Phase 4